Provocholine Inhalation Solution
Product Images NDC 64281-116

8 FDA label images from Methapharm Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Provocholine Inhalation Solution (NDC 64281-116). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Methapharm Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Graph (Graph)

Graph (Graph)
A line graph depicting the relationship between the strength of Provocholine and the percentage fall in FEV1. The x-axis represents the strength of Provocholine, ranging from 0 to 16, and the y-axis shows the percent fall in FEV1 from 0 to 25%. The graph shows a rising curve indicating increasing fall in FEV1 with higher Provocholine strength, marking a specific point labeled PC20.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of Methacholine Chloride, the active ingredient in Provocholine Inhalation Solution. The diagram shows the molecular arrangement including a quaternary ammonium group and a chloride ion (Cl^-).*
FDA Label Image

Methapharm (Methapharm)

FDA Label Image

Carton (Carton 16mg mL)

Carton (Carton 16mg mL)
Packaging label for Provocholine Inhalation Solution 16 mg/mL (48 mg/3 mL), a methacholine chloride inhalation solution kit by Methapharm Inc. The label indicates it contains 12 vials of 3 mL each and three pouches of four vials, intended for oral inhalation use only. Storage instructions and non-medicinal ingredients are also listed, along with contact information for the manufacturer.*
FDA Label Image

Carton (Carton 100mg)

Carton (Carton 100mg)
Packaging label for Provocholine (methacholine chloride USP) powder for solution, 100 mg strength. The label indicates it contains six 20 mL containers and is intended for oral inhalation only, with a warning that it is not for injection. The labeler is Methapharm Inc., and the product is marked Rx Only.*
FDA Label Image

Vial100mg (Vial 100mg)

Vial100mg (Vial 100mg)
Label for Provocholine 100 mg (methacholine chloride USP) powder for solution, indicated for oral inhalation use. The label includes NDC 64281-100-00, distributed by Methapharm Inc., Boca Raton, FL. It specifies a 20 mL container, with space for lot number and expiration date. The label also contains placeholders for 2D codes and a barcode.*
FDA Label Image

Foil Pouches (Foil Pouches)

Foil Pouches (Foil Pouches)
Provocholine Inhalation Solution (methacholine chloride) packaging labels showing multiple strengths in 3 mL vials including 0.25 mg/mL, 0.0625 mg/mL, 1 mg/mL, 4 mg/mL, 16 mg/mL, and a Base Solution with no methacholine chloride. Each label states single-dose use for oral inhalation only, storage instructions, and is manufactured for Methapharm, Inc.*
FDA Label Image

Cartons (Cartons)

Cartons (Cartons)
Provocholine Inhalation Solution kit packaging label detailing methacholine chloride as the active ingredient. Contains 6 vials of 3 mL each at various concentrations ranging from 0.0625 mg/mL to 16 mg/mL. Label indicates use for oral inhalation only, single dose, sterile solution, and includes storage instructions along with manufacturer Methapharm Inc. information and barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.